Skip to main content
Log in

Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT). The aim of the present study was to investigate the frequency of this and other 2 known CaR polymorphisms (R990G and Q1011E) in patients with PHPT and their effect on its phenotype. We studied 103 Italian patients with PHPT and 148 healthy Italian subjects and we compared the results in 50 pairs matched for sex, age and geographic provenience. A fragment of exon 7 of the CaR gene, containing the 3 polymorphic loci of interest (A986S, R990G, and Q1011E), was amplified by PCR and sequenced. Serum calcium and PTH levels, BMD and other biochemical and clinical parameters were evaluated. The frequency distribution of the A986S, R990G, and Q1011E polymorphisms in the 103 PHPT patients was 39.8%, 5.8%, and 2.0%, respectively. There was no difference in the frequency of the 3 CaR polymorphisms in the 50 matched pairs of patients and controls. We found no significant difference in several clinical and biochemical parameters between PHPT patients carrying or not the 986S allele. Finally, no relationship was observed between the 986S genotype and total and ionized serum calcium in control subjects. The A986S CaR polymorphism is the most common in Italian PHPT patients and the allotype AS does not appear to play a relevant role in the pathogenesis of PHPT and its severity. The A986S polymorphism does not correlate with serum calcium levels in normal Italian subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chattopadhyay N., Mithal A., Brown E.M. The calcium sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr. Rev. 1996, 17: 289–307.

    PubMed  CAS  Google Scholar 

  2. Pearce S.H.S., Thakker R.V. The calcium-sensing receptor: insight into extracellular calcium homeostasis in health and disease. J. Endocrinol. 1997, 99: 88–96.

    Google Scholar 

  3. Pollak M., Brown E.M., Estep H.L. et al. Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993, 75: 1297–1303.

    Article  PubMed  CAS  Google Scholar 

  4. Pearce S., Trump D., Wooding C. et al. Calcium sensing receptor mutations in familial benign hypercalcemia and neonatal severe hyperparathyroidism. J. Clin. Invest., 1995, 96: 2683–2692.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  5. Heath H. III, Odelberg S., Jackson C.E. et al. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J. Clin. Endocrinol. Metab. 1996, 81: 1312–1317.

    Article  PubMed  CAS  Google Scholar 

  6. Pollak M.R., Brown E.M., Estep H.L. et al. Autosomal dominant hypocalcemia caused by a Ca2+-sensing receptor gene mutation. Nat. Genet. 1994, 8: 303–307.

    Article  PubMed  CAS  Google Scholar 

  7. Pearce S., Williamson C., Kifor O., et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium sensing receptor. N. Engl. J. Med. 1996, 335: 1115–1122.

    Article  PubMed  CAS  Google Scholar 

  8. Hosokawa Y, Pollak M.R., Brown E.M., Arnold A. Mutation analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors. J. Clin. Endocrinol. Metab. 1995, 80: 3107–3110.

    PubMed  CAS  Google Scholar 

  9. Cetani F., Pinchera A., Pardi E. et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J. Bone Miner. Res. 1999, 14: 878–882.

    Article  PubMed  CAS  Google Scholar 

  10. Chikatsu N., Fukumoto S., Takeuchi Y. et al. Cloning and characterization of two promoters for the human calciumsensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. J. Biol. Chem. 2000, 275: 7553–7557.

    Article  PubMed  CAS  Google Scholar 

  11. Kifor O., Moore F.D., Wang P. et al. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1996, 81: 1598–1606.

    PubMed  CAS  Google Scholar 

  12. Gogusev J., Duchambon P., Hory B. et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 1997, 51: 328–336.

    Article  PubMed  CAS  Google Scholar 

  13. Farnebo F., Enberg U., Grimelius L. et al. Tumor-specific decreased expression of calcium-sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1997, 82: 3481–3486.

    PubMed  CAS  Google Scholar 

  14. Cetani F., Picone A. Cerrai P. et al. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca2+ set-point in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 2000, 85: 4789–4794.

    PubMed  CAS  Google Scholar 

  15. Rubin L.A., Peltekova V., Janic N. et al. Calcium sensing receptor gene: analysis of polymorphism frequency. Scand. J. Clin. Lab. Invest. 1997, 57: 122–125.

    Article  CAS  Google Scholar 

  16. Cole D.E.C., Peltekova V., Rubin L.A. et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentration. Lancet 1999, 353: 112–115.

    Article  PubMed  CAS  Google Scholar 

  17. Cole D.E.C., Vieth R., Trang H.M., Womg B.Y.L., Hendy G.N., Rubin L.A. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor. Mol. Genet. Metab. 2001, 72: 168–174.

    Article  PubMed  CAS  Google Scholar 

  18. Miedlich S., Lamesch P., Mueller A., Paschke R. Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 2001, 145: 421–427.

    Article  PubMed  CAS  Google Scholar 

  19. Yamauchi M., Sugimoto T., Yamaguchi T. et al. Association of polymorphic alleles of the calcium sensing receptor gene with the clinical severity of primary hyperparathyroidism. Clin. Endocrinol. 2001, 55: 373–379.

    Article  CAS  Google Scholar 

  20. Potts J.T. (Ed). NIH Consensus Development Conference Statement on Primary Hyperparathyroidism. J. Bone Miner. Res. 1991, 6: S9–S13.

    Google Scholar 

  21. Marcocci C., Golia F., Bruno-Bossio G., Vignali E., Pinchera A. Carefully monitored levothyroxine therapy is not associated with bone loss in premenopausal women. J. Clin. Endocrinol. Metab. 1994, 78: 818–823.

    PubMed  CAS  Google Scholar 

  22. Sambrook J., Fitsch E.F., Maniatis T. Molecular cloning: A laboratory manual 2nd ed., Cold Spring Harbor laboratory, Cold Spring Harbor, New York, 1989, vol 1, 2, E3–E5.

    Google Scholar 

  23. Bilezikian J.P., Silverberg S.J., Gartenberg F. et al. Clinical presentation of primary hyperparathyroidism. In: Bilezikian J.P., Levine M.A., Marcus R. (Eds.), The Parathyroids. Raven Press, Ltd., New York, 2001, p 457.

    Google Scholar 

  24. Carling T., Kindmark A., Hellman P., et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nat. Med. 1995, 1: 1309–1311.

    Article  PubMed  CAS  Google Scholar 

  25. Carling T., Rastad J., Akerstrom G., Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J. Clin. Endocrinol. Metab. 1998, 83: 2255–2258.

    PubMed  CAS  Google Scholar 

  26. Carling T., Rastad J., Kindmark A., Lundgren E., Ljunghall S., Akerstrom G. Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyrodism. Surgery 1997, 122: 1101–1105.

    Article  PubMed  CAS  Google Scholar 

  27. Khosla S., Ebeling P.R., Firek A.F., Burritt M.M., Kao P.C., Heath III H. Calcium infusion suggests a “set-point” abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism J. Clin. Endocrinol. Metab. 1993, 76: 715–720.

    PubMed  CAS  Google Scholar 

  28. Rao D.S Parathyroidectomy for asymtomatic primary hyperparathyroidism (PHPT): is it worth the risk? J. Endocrinol. Invest. 2001, 24: 131–134.

    Article  PubMed  CAS  Google Scholar 

  29. Rastad J. Parathyroidectomy for asymtomatic primary hyperparathyroidism (PHPT): is it worth the risk? J. Endocrinol. Invest. 2001, 24: 56–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Marcocci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cetani, F., Borsari, S., Vignali, E. et al. Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism. J Endocrinol Invest 25, 614–619 (2002). https://doi.org/10.1007/BF03345085

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345085

Key-words

Navigation